439 related articles for article (PubMed ID: 18786563)
21. Janus kinase/signal transducer and activator of transcription inhibitors enhance the protective effect mediated by tanshinone IIA from hypoxic/ischemic injury in cardiac myocytes.
Zhang MQ; Tu JF; Chen H; Shen Y; Pang LX; Yang XH; Sun RH; Zheng YL
Mol Med Rep; 2015 Apr; 11(4):3115-21. PubMed ID: 25502794
[TBL] [Abstract][Full Text] [Related]
22. The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.
Tao W; Wen F; Zhang H; Liu G
Brain Dev; 2009 Mar; 31(3):200-7. PubMed ID: 18715729
[TBL] [Abstract][Full Text] [Related]
23. Nuclear protein IkappaB-zeta inhibits the activity of STAT3.
Wu Z; Zhang X; Yang J; Wu G; Zhang Y; Yuan Y; Jin C; Chang Z; Wang J; Yang X; He F
Biochem Biophys Res Commun; 2009 Sep; 387(2):348-52. PubMed ID: 19595668
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-10 protects the ischemic heart from reperfusion injury via the STAT3 pathway.
Manukyan MC; Alvernaz CH; Poynter JA; Wang Y; Brewster BD; Weil BR; Abarbanell AM; Herrmann JL; Crowe BJ; Keck AC; Meldrum DR
Surgery; 2011 Aug; 150(2):231-9. PubMed ID: 21719057
[TBL] [Abstract][Full Text] [Related]
25. Tackling myocardial ischemic injury: the signal transducer and activator of transcription 3 (STAT3) at a good site.
Yang Y; Hu W; Di S; Ma Z; Fan C; Wang D; Jiang S; Li Y; Zhou Q; Li T; Luo E
Expert Opin Ther Targets; 2017 Feb; 21(2):215-228. PubMed ID: 28001439
[TBL] [Abstract][Full Text] [Related]
26. Cardioprotection of post-ischemic moderate ROS against ischemia/reperfusion via STAT3-induced the inhibition of MCU opening.
Wu L; Tan JL; Chen ZY; Huang G
Basic Res Cardiol; 2019 Aug; 114(5):39. PubMed ID: 31463567
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.
Mitsuyama K; Matsumoto S; Masuda J; Yamasakii H; Kuwaki K; Takedatsu H; Sata M
Anticancer Res; 2007; 27(6A):3749-56. PubMed ID: 17970038
[TBL] [Abstract][Full Text] [Related]
28. Co-activator SRC-1 is dispensable for transcriptional control by STAT3.
Cvijic H; Bauer K; Löffler D; Pfeifer G; Blumert C; Kretzschmar AK; Henze C; Brocke-Heidrich K; Horn F
Biochem J; 2009 Apr; 420(1):123-32. PubMed ID: 19203349
[TBL] [Abstract][Full Text] [Related]
29. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria.
Samavati L; Rastogi R; Du W; Hüttemann M; Fite A; Franchi L
Mol Immunol; 2009 May; 46(8-9):1867-77. PubMed ID: 19299019
[TBL] [Abstract][Full Text] [Related]
30. Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart.
Terrell AM; Crisostomo PR; Wairiuko GM; Wang M; Morrell ED; Meldrum DR
Shock; 2006 Sep; 26(3):226-34. PubMed ID: 16912647
[TBL] [Abstract][Full Text] [Related]
31. An RNA biding protein, Y14 interacts with and modulates STAT3 activation.
Ohbayashi N; Taira N; Kawakami S; Togi S; Sato N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Matsuda T
Biochem Biophys Res Commun; 2008 Aug; 372(3):475-9. PubMed ID: 18503751
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
Skyschally A; Schulz R; Heusch G
Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
[TBL] [Abstract][Full Text] [Related]
33. The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review).
Wang SW; Sun YM
Int J Oncol; 2014 Apr; 44(4):1032-40. PubMed ID: 24430672
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury.
Ruiz-Meana M; Rodríguez-Sinovas A; Cabestrero A; Boengler K; Heusch G; Garcia-Dorado D
Cardiovasc Res; 2008 Jan; 77(2):325-33. PubMed ID: 18006437
[TBL] [Abstract][Full Text] [Related]
35. Aberrant activation of interleukin-9 receptor and downstream Stat3/5 in primary T-cell lymphomas in vivo in susceptible B6 and resistant C3H mice.
Shang Y; Kakinuma S; Amasaki Y; Nishimura M; Kobayashi Y; Shimada Y
In Vivo; 2008; 22(6):713-20. PubMed ID: 19180996
[TBL] [Abstract][Full Text] [Related]
36. Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling.
Kurdi M; Booz GW
J Cardiovasc Pharmacol; 2007 Aug; 50(2):126-41. PubMed ID: 17703129
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-6 promotes 2-deoxyglucose uptake through p44/42 MAPKs activation via Ca2+/PKC and EGF receptor in primary cultured chicken hepatocytes.
Suh HN; Lee YJ; Han HJ
J Cell Physiol; 2009 Mar; 218(3):643-52. PubMed ID: 19006119
[TBL] [Abstract][Full Text] [Related]
38. Many good reasons to have STAT3 in the heart.
Hilfiker-Kleiner D; Hilfiker A; Drexler H
Pharmacol Ther; 2005 Jul; 107(1):131-7. PubMed ID: 15963355
[TBL] [Abstract][Full Text] [Related]
39. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects.
Suzuki S; Tanaka K; Suzuki N
J Cereb Blood Flow Metab; 2009 Mar; 29(3):464-79. PubMed ID: 19018268
[TBL] [Abstract][Full Text] [Related]
40. Regulation of Stat3 transcriptional activity by the conserved LPMSP motif for OSM and IL-6 signaling.
Sun W; Snyder M; Levy DE; Zhang JJ
FEBS Lett; 2006 Oct; 580(25):5880-4. PubMed ID: 17027757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
